MOESM1 of Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate

Additional file 1: Table S1. Expanded soluble readout panel for each BioMAP system. Figure S1. BioMAP profiles.补充材料1：表S1。各BioMAP系统的扩展可溶性检测指标面板。图S1：BioMAP特征谱。